Liquid Biopsy Decoded: Data, Diagnostics, and the Future of Cancer Care

How do we move from discovery to action in the fight against cancer? In this inaugural episode of the Decoded podcast, Dr. Jurgi Camblong speaks with Professor Umberto Malapelle, one of the leading voices in molecular diagnostics and liquid biopsy, to explore how precision data is reshaping the fight against cancer.Together, they decode the evolving role of pathology, tracing the shift from glass slides to genomic signals and the rise of liquid biopsy as a dynamic, non-invasive tool in cancer care.Professor Malapelle reveals how integrating molecular insights is making diagnostics more precise, accessible, and equitable - while empowering clinicians to personalize treatment at scale.The conversation unpacks the real-world impact of liquid biopsy, the economics of molecular testing, and why the future of cancer care depends on both collaboration and a new generation of digitally fluent healthcare professionals.Listen in for:Insights on where cancer diagnostics is headingThe power - and challenge - of integrating complex data in medicineWhy liquid biopsy is more than a buzzwordThis is the future of oncology, decoded.Explore more: https://www.sophiagenetics.com/podcasts/